Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance at the beginning at Dec. 31, 2020 $ (3,496,499) $ 14 $ 2,044,362 $ (5,540,875)
Balance at the beginning (in shares) at Dec. 31, 2020   142,369    
Exchange of common shares of Marpai Health, Inc. (see Note 1) (14) $ (14)    
Exchange of common shares of Marpai Health, Inc. (in shares)   (142,369)    
Issuance of common shares of Marpai, Inc. (see Note 1) (1) 17,351,935 $ 1,115 17,350,820  
Issuance of common shares of Marpai, Inc. (in shares)   11,147,302    
Issuance of common shares in connection with initial public offering, net 24,547,085 $ 718 24,546,367  
Issuance of common shares in connection with initial public offering, net (in shares)   7,187,500    
Conversion of convertible notes to common stock in connection with initial public offering 5,106,554 $ 171 5,106,383  
Conversion of convertible notes to common stock in connection with initial public offering (in shares)   1,712,162    
Exercise of warrant 900,000 $ 23 899,977  
Exercise of warrant (in shares)   225,000    
Issuance of common stock upon exercise of stock options 61 $ 3 58  
Issuance of common stock upon exercise of stock options (in shares)   27,763    
Warrants issued for cash 53,333   53,333  
Share-based compensation 1,230,792   1,230,792  
Net loss (15,984,835)     (15,984,835)
Balance at the end at Dec. 31, 2021 $ 29,708,412 $ 2,030 51,232,092 (21,525,710)
Balance at the end (in shares) at Dec. 31, 2021 20,299,727 20,299,727    
Issuance of common stock upon exercise of stock options $ 206 $ 9 197  
Issuance of common stock upon exercise of stock options (in shares)   89,631    
Share-based compensation 2,855,385   2,855,385  
Issuance of stock upon vesting of restricted stock units 85 $ 85    
Issuance of stock upon vesting of restricted stock units (in shares)   852,174    
Shares issued to vendors in exchange for services 38,627 $ 4 38,623  
Shares issued to vendors in exchange for services (in shares)   37,500    
Net loss (26,468,390)     (26,468,390)
Balance at the end at Dec. 31, 2022 $ 6,134,325 $ 2,128 $ 54,126,297 $ (47,994,100)
Balance at the end (in shares) at Dec. 31, 2022 21,279,032 21,279,032